Author

Adrienne Vancura

University of BernORCID 0000-0002-7990-0559Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Assay:CRISPR screen· 1 Research Focus:differential expression· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Adrian F. OchsenbeiniD· 2 shared Álvaro AndradesiD· 2 shared Andrés LanzósiD· 2 shared Carsten RietheriD· 2 shared Dominik F. Meise· 2 shared Giulia Basile· 2 shared Hugo Guillen-RamireziD· 2 shared Michaela RoemmeleiD· 2 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Adrian F. OchsenbeinORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Molecular BiologyMolecular CellPeer-reviewedJul 1, 2023

Transcription factors interact with RNA to regulate genes

Ozgur Oksuz, Jonathan E. Henninger, Robert Warneford-Thomson…·Richard A. Young

The paper identifies RNA-binding as a common feature of transcription factors, showing it contributes to gene regulation and is conserved in vertebrates.

275 citationstop 1%

𝕏 PostBluesky

GenomicsNature CommunicationsPeer-reviewedJun 8, 2023

Tumour mutations in long noncoding RNAs enhance cell fitness

Roberta Esposito, Andrés Lanzós, Tina Uroda…·Rory Johnson

The paper identifies mutated long noncoding RNAs (lncRNAs) as contributors to tumour cell fitness through experimental validation of their oncogenic effects.

22 citations

humanwhole-exome sequencing

𝕏 PostBluesky

GenomicsCell GenomicsPeer-reviewedAug 22, 2022

Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities

Roberta Esposito, Taisia Polidori, Dominik F. Meise…·Rory Johnson

The paper identifies 60 high-confidence oncogenic lncRNAs in NSCLC using CRISPR deletion screens and ASO validation, revealing therapeutic vulnerabilities.

35 citations

humanCRISPR screen

𝕏 PostBluesky